Videos
WEBINAR: September 3, 2025
Next-gen vectors: advancing in vivo and ex vivo gene delivery through intelligent design
Nagy Habib MD, ChM, FRCS, CEO, Dawn Therapeutics
John Maher, MD, Chief Science Officer, Leucid Bio
Carlo Scala, Director of Process Development and Innovation, ViroCell Biologics
Moderator: Abigail Pinchbeck, Editor, BioInsights
PANEL: April 16, 2025
Advancing Gene Therapies for Rare Diseases: Implementing Novel Strategies for Not-For-Profit Innovation
Alliance for Regenerative Medicine, Rome
Our CEO John W. Hadden II was honored to moderate these accomplished panelists:
Hilary Eaton, PhD, Chief Business Officer, Profluent.bio
Sadik Kassim, PhD, Chief Scientific Officer and Chief Technology Officer, Danaher Genomic Medicines
Maryam Mokhtarzadeh, MD, Senior Director, Regulatory Strategy, REGENXBIO
Hilary Schultz, CEO and Founder, Persephoni BioPartners